Journals / BEYOGLU EYE JOURNAL / 2018 / Cilt: 3 - Sayı: 1

Changes in Central Macular Thickness after Uncomplicated Phacoemulsification Surgery in Diabetic and Non-Diabetic Patients

Pages
13–19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These changes were more prominent in eyes with NPDR than in eyes with no-DR and those of the control group

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study was to assess changes in central macular thickness following uncomplicated phacoemulsification surgery in diabetic patients with and without retinopathy and in a control group.Methods: The records of 43 eyes of patients with mild non-proliferative diabetic retinopathy (NPDR), 43 eyes of diabetic patients without diabetic retinopathy (no-DR), and 43 eyes of a control group that also underwent phacoemulsification surgery were prospectively reviewed.
📊
Key Findings & Data:Foveal thickness was measured using optical coherence tomography preoperatively and at 1 week and 1, 3, 6, and 12 months postoperatively.Results: No clinically significant differences in foveal thickness were observed preoperatively between groups.
💡
Conclusion & Impact:These changes were more prominent in eyes with NPDR than in eyes with no-DR and those of the control group
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of this study was to assess changes in central macular thickness following uncomplicated phacoemulsification surgery in diabetic patients with and without retinopathy and in a control group.Methods: The records of 43 eyes of patients with mild non-proliferative diabetic retinopathy (NPDR), 43 eyes of diabetic patients without diabetic retinopathy (no-DR), and 43 eyes of a control group that also underwent phacoemulsification surgery were prospectively reviewed. Foveal thickness was measured using optical coherence tomography preoperatively and at 1 week and 1, 3, 6, and 12 months postoperatively.Results: No clinically significant differences in foveal thickness were observed preoperatively between groups. Foveal thickness had increased in the NPDR group at 1 week and 1 and 3 months after surgery, in the no-DR group at 1 week and 1 month, and in the control group at 1 week after surgery. Foveal thickness decreased gradually in the NPDR group after 3 months. When comparing the groups, foveal thickness was significantly greater in the NPDR group than in the noDR group and the control group at postoperative months 1 and 3; however, at month 6, the differences had decreased, and there were no clinically significant differences between groups.Conclusion: Foveal thickness increased until 3 months after cataract surgery and decreased gradually thereafter in NPDR patients. Foveal thickness had also increased during the first month in the no-DR group. Foveal thickness increased only in the first week in the control group. These changes were more prominent in eyes with NPDR than in eyes with no-DR and those of the control group

🔖

Cite This Article

AKKAYA, S., ÖZKURT, Y. (2018). Changes in Central Macular Thickness after Uncomplicated Phacoemulsification Surgery in Diabetic and Non-Diabetic Patients. BEYOGLU EYE JOURNAL, Cilt: 3 - Sayı: 1, 13–19. https://ajindex.com/articles/147262

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Song E, Sun H, Xu Y, Ma Y, Zhu H, Pan CW. Age-related cataract, cataract surgery and subsequent mortality: a systematic review and meta-analysis. PLoS One 2014;9:e112054
  2. Klein BE, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol 1995;119:295–300
  3. Romero-Aroca P. Targeting the pathophysiology of diabetic macular edema. Diabetes Care 2010;33:2484–5
  4. Chae JB, Joe SG, Yang SJ, Lee JY, Sung KR, Kim JY, et al. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy. Retina 2014;34:149–56
  5. Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 2002;240:735–8
  6. Dowler JG, Hykin PG, Lightman SL, Hamilton AM. Visual acuity following extracapsular cataract extraction in diabetes: a meta-analysis. Eye (Lond) 1995;9:313–7
  7. Zaczek A, Olivestedt G, Zetterström C. Visual outcome after phacoemulsification and IOL implantation in diabetic patients. Br J Ophthalmol 1999;83:1036–41
  8. Chew EY, Benson WE, Remaley NA, Lindley AA, Burton TC, Csaky K, et al. Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. Arch Ophthalmol 1999;117:1600–6
  9. Jaffe GJ, Burton TC, Kuhn E, Prescott A, Hartz A. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol 1992;114:448–56
  10. Schatz H, Atienza D, McDonald HR, Johnson RN. Severe diabetic retinopathy after cataract surgery. Am J Ophthalmol 1994;117:314–21
  11. Mittra RA, Borrillo JL, Dev S, Mieler WF, Koenig SB. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch Ophthalmol 2000;118:912–7
  12. Chung J, Kim MY, Kim HS, Yoo JS, Lee YC. Effect of cataract surgery on the progression of diabetic retinopathy. J Cataract Refract Surg 2002;28:626–30
  13. Schrey S, Krepler K, Biowski R, Wedrich A. Midterm visual outcome and progression of diabetic retinopathy following cataract surgery. Midterm outcome of cataract surgery in diabetes. Ophthalmologica 2002;216:337–40
  14. Romero-Aroca P, Fernández-Ballart J, Almena-Garcia M, Méndez-Marín I, Salvat-Serra